Clinical Resources Articles
These sleep medicine articles include updates about coding and reimbursement, new practice guidelines, and telemedicine. To view our case study of the month, visit the AASM sleep medicine case studies page.
FDA safety alert warns of respiratory depression risk with restless legs syndrome drugs
The FDA has issued a safety alert warning that serious breathing difficulties may occur in patients with respiratory risk factors who are using gabapentin (Neurontin, Gralise, Horizant) or pregabalin (Lyrica, Lyrica CR). These risk factors include the use of opioid pain medicines and other [...]
